Title: The Effect of Nafamostat Mesilate Infusion after ERCP for Post-ERCP Pancreatitis
Version: 1 Date: 26 Nov 2021
Reviewer's report:
On a page 5/17  "Study design ant patients" in a paragraph two, third sentence  starts with the
word "Nafasmotat" . Please correct the word to "Nafamostat".
Title: The Effect of Nafamostat Mesilate Infusion after ERCP for Post-ERCP Pancreatitis
Version: 1 Date: 26 Nov 2021
Reviewer's report:
On a page 5/17  "Study design ant patients" in a paragraph two, third sentence  starts with the
word "Nafasmotat" . Please correct the word to "Nafamostat".
Please review this paper.
user
Title: The Effect of Nafamostat Mesilate Infusion after ERCP for Post-ERCP Pancreatitis
Version: 1 Date: 26 Nov 2021
Reviewer's report:
On a page 5/17  "Study design ant patients" in a paragraph two, third sentence  starts with the
word "Nafasmotat" . Please correct the word to "Nafamostat".
assistant